OOIR: Observatory of International Research

Papers

(The H4-Index of European Heart Journal is 97. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Meet the European Society of Cardiology Gold Medallists 2022	2884
Corrigendum to: Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled	2621
Correction to: The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies	2033
Weekly journal scan: a hard RAFTing to improve long-term survival in heart failure with severely reduced ejection fraction	1908
Strengthening cardiovascular trials across Australia and New Zealand—the Alliance for Cardiovascular Trials (ANZACT) Network	1598
Unmeasured confounding is always unnerving: cannabis and cardiovascular risk	1419
Additional value of 18fluorodeoxyglucose positron emission tomography/computed tomography combined with intracardiac echocardiography to detect lead vegetations	1272
Obituary Joep Perk	1249
Taking inspiration from birds to improve flow in prosthetic heart valves: an European Research Council granted project	1042
The extended role of 24 h ambulatory blood pressure monitoring for reflex syncope	953
Risk of knowing too much: the tricky case of estimated glomerular filtration rate and treatment decisions in heart failure	936
Doubly committed ventricular septal defect closure using an eccentric occluder via minimal incision in the anterior median sternum through the left parasternal third intercostal space	847
Elevated serum xylitol levels and cardiovascular risk: an active component or an innocent bystander?	809
Isolated early peak cardiac troponin for clinical decision-making after elective cardiac surgery: useless at best	807
Pulmonary haemodynamics and pulmonary congestion: where are we now?	763
The Antwerp score: is this the ‘new hope on the horizon’?	505
Female representation on editorial boards of the National Societies of Cardiology Journals of the European Society of Cardiology	486
A rare case of a dorsal mass caused by descending thoracic aortic dissection	457
New Guidelines and a focus on ischaemic heart disease, atrial fibrillation, innovative treatments of channelopathies	417
Residual leaks after transcatheter left atrial appendage closure: why and how to assess it?	392
Intricacies of aortic risk assessment studies: not a simple matter	364
Corrigendum to: Backup natural pacemaker found in the heart	335
Beyond modality: unaddressed variables and comorbidities in exercise interventions for coronary artery disease	281
Breakthrough outflow tract unlocking: modified transapical balloon-assisted transseptal mitral annuloplasty for high-risk mitral valve-in-ring patients	237
Arterial conduits for coronary bypass grafting: the set-point concept	235

Bulgarian Society of Cardiology: 50 years on	227
Weekly Journal Scan: no CLEAR evidence of cardiovascular benefits of colchicine after acute myocardial infarction	215
Early vascular disease of Olympian Paavo Nurmi despite a healthy lifestyle	212
Use of emgliflozine in cardiotoxicity treatment. EMPACARD-treatment registry. Six-months follow-up	205
Synthetic assessment of cardiac autonomic modulation and Baevsky stress index in patients with synucleinopathies	204
From a club of friends to an institution: past successes and future challenges for the European Society of Cardiology	204
Correction to: Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score	186
Expression changes of circulating ACE2 regulating-microRNA profiles in patients with COVID-19 during hospitalisation	183
Patient characteristics and incidence of cardiac amyloidosis: an observational study in the UK clinical setting using electronic health records	179
Association of Body mass index and clinical outcomes in patient with coronary artery disease undergoing percutaneous coronary intervention	176
Increased right amygdala activity during the hyper-acute phase of takotsubo syndrome	176
Interleukin-6 signalling, lipoprotein (a) lowering and cardiovascular disease: a mendelian randomisation study	173
Diffusion tensor imaging to assess myocardial microstructure after infarction by magnetic resonance	168
Preserved left ventricular ejection fraction with abnormal myocardial work in sepsis	168
Heart failure with preserved ejection fraction: underdiagnosed and undertreated in patients with tricuspid regurgitation	162
Surgical myectomy for hypertrophic cardiomyopathy: procedural volume and outcomes	161
Comparison of rapid test for high-sensitivity troponin I with laboratory high-sensitivity troponin T in patients with acute chest pain - a prospective monocentric study	161
Immune cells in cardiac homeostasis and disease: emerging insights from novel technologies	158
Air pollutants, genetic susceptibility, and abdominal aortic aneurysm risk: a prospective study	156
Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial	156
Fate of the unoperated ascending thoracic aortic aneurysm: three-decade experience from the Aortic Institute at Yale University	155
Association of transcatheter edge-to-edge repair with improved survival in older patients with severe, symptomatic degenerative mitral regurgitation	152
Nocturnal heat exposure and stroke risk	149
Correction to: 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary sy	149
Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-T	147
Beyond reproductive health: the cardiovascular risks of endometriosis	146
Weekly Journal Scan: The promise of small interfering RNA in reducing lipoprotein(a)	145
The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications	139
Breathing danger: linking air pollution to cardiovascular disease and increased risk of abdominal aortic aneurysm	137
Blood biomarkers in left-sided valvular heart disease	136
The COVID-19 pandemic and heart failure: lessons from GUIDE-HF	134
Novel DES cardiomyopathy presenting with lifelong syncope: diagnostic breakthrough via multimodal imaging and insertable cardiac monitor	134
Dementia in individuals with severe hypercholesterolemia: Korean nationwide cohort study	134
The gender difference in cause of death in Japanese atrial fibrillation patients: The Fushimi AF Registry	132
Differences in left atrial stain, endothelial glycocalyx, arterial elasticity and myocardial efficiency between ESUS, lacunar, cardioembolic and atherosclerotic type of stroke	132
Recent cardiac rehabilitation and its impact on cardiopulmonary exercise test variables in Brazilian cardiac transplant recipients	132
Cardiac troponin fragmentation in marathon runners. The MaraCat2 study	130
Multiparametric risk predictions for morbidity and mortality in patients with pulmonary arterial hypertension: insights from a nation-wide registry	130
Acute infections and inflammatory biomarkers in patients with acute pulmonary embolism	130
Echocaridographic assessment of pulmonary hypertension: improving the probability	129
Twenty-year trends in peripheral artery disease, lower extremity revascularization, and lower extremity amputation in newly diagnosed type 2 diabetes	128
Evaluating the safety and long-term efficacy of triple vasodilator therapy for pulmonary arterial hypertension associated with congenital heart disease	127
Physiological disease pattern as assessed by PPGI in vessels with FFR and iFR discordance	126
Cumulative accelerometer-based light physical activity from childhood through young adulthood progressively decreases left ventricular mass in British youth: a 13-year longitudinal study	125
Clinical outcomes of deferred lesions by IVUS versus FFR-guided treatment decision: the FLAVOUR trial substudy	124
Novel cardiovascular magnetic resonance imaging heterogeneity biomarkers to diagnose and predict cardiovascular disease: a UK Biobank CMR strain study	123
T regulatory cells lose their protective phenotype in patients with coronary artery disease (CAD)	121
Continuous monitoring of heart failure biomarker using a sensitive graphene-based electrical sensor	121
Prevalence of diabetic nephropathy and subsequent cardiovascular outcomes: a nationwide study of 74,014 patients with type 2 diabetes	120
Association between the changes in walking speed during 6 months after discharge and subsequent prognosis in older patients with heart failure: report from a multicenter prospective cohort study	119

Real-time electrophysiological characterization of acute and chronic radiofrequency ablation lesions	119
Left main coronary artery dimension and variation in Thai population	118
New definition of hypotension in patients with reflex syncope using 24-hour ambulatory blood pressure monitoring (SynABPM Study)	115
Validation of HAS-BELD scoring system and risk factors of bleeding with warfarin among non-valvular atrial fibrillation patients	115
Spontaneous, independent, single-center renal denervation registry of a resistant hypertension multidisciplinary team	114
Deep learning for fully automated echocardiographic measurements of left ventricular wall thickness and chamber dimensions in the parasternal long-axis view	112
Epicardial adipose tissue volume and density is associated with cardiac dysfunction in asymptomatic people with type 2 diabetes	110
Management of hospital resources for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) - an approach to deescalate ?	110
The expression of selected microRNAs enables identification of patients with functional atrial tricuspid regurgitation. New insights into TR pathophysiology	108
Early diastolic strain rate and its associations with estimated glomerular filtration rate and albuminuria	108
Atherogenic lipoprotein profile associated with anthropometric indices of obesity and their association with cardiometabolic risk markers: a cross-sectional study in community	107
Survival penalty in patients undergoing transcatheter versus surgical aortic valve replacement: is it just a question of frailty? Insights from a large cohort with demographic matching	103
Post-systolic shortening index by echocardiography evaluation of dyssynchrony in the non-dilated and hypertrophied left ventricle	103
Permanent pacemaker implantation is associated with an increased risk of heart failure hospitalization in transcatheter aortic valve implantation patients with reduced systolic function	103
Right ventricular free wall longitudinal strain (RVFWSL) a new outcome predictor in patients candiate for TAVI	103
Implementing dynamic atrioventricular delay optimization for cardiac resynchronization therapy: an economic analysis in the EU5 countries	102
Practicing what you preach. Do cardiology trainees in the United Kingdom follow the lifestyle advice that they would give to patients?	101
What is there to EAARN with a CRT implantation? Predictive factors of mortality or clinical deterioration in patients receiving cardiac resynchronization therapy based on pre-implant factors	100
Extraction of leadless and tranvenous pacemakers: occurrence, causes and complications from a national US database	99
Improving early mortality risk detection in light-chain cardiac amyloidosis patients with routine echocardiographic indicators and mayo staging	99
Dietary sodium intake and outcomes: a secondary analysis from SODIUM - HF	99
Factors for incorrect automated atrial fibrillation identification in large-scale screening	99